NCT06000085

Brief Summary

The aim of the present study is to assess Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in class II cavities of primary molars regarding the following objectives: The primary objective To evaluate and compare the clinical performance of Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in restoring class II cavities of primary molars after 3,6, and 12 months. The secondary objective To assess the effect of different independent variables on the treatment outcome of the experimental restorative materials. Research question: Is there a difference in the clinical performance between flowable giomers and highly viscous glass ionomer in restoring class II cavities of primary molars? Null Hypothesis There is no difference in the clinical performance between Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) after one year of follow up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

1.4 years

First QC Date

August 11, 2023

Last Update Submit

September 8, 2023

Conditions

Keywords

proximal cariesprimary molarsflowable giomerequia forte

Outcome Measures

Primary Outcomes (1)

  • The clinical performance of Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in restoring class II cavities of primary molars

    The restorations will be evaluated using the FDI criteria having esthetic, functional, and biological properties

    12 months

Secondary Outcomes (1)

  • The effect of different independent variables on the treatment outcome of the experimental restorative materials.

    12 months

Study Arms (2)

Flowable Giomer Beautifil flow plus x

EXPERIMENTAL

injectable flowable restorative material

Procedure: restoration of proximal cavities of primary molars with flowable giomer

Glass-hybrid-added HVGIC Equia Forte

ACTIVE COMPARATOR

Glass-hybrid-added Highly viscous glass ionomer cement

Procedure: restoration of proximal cavities of primary molars with highly viscous glass ionomer cement

Interventions

removal of proximal caries of primary molars and restoration of the cavities prepared by beautifil flow plus x

Flowable Giomer Beautifil flow plus x

removal of proximal caries of primary molars and restoration of the cavities prepared by equia forte

Glass-hybrid-added HVGIC Equia Forte

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • to 8 years old medically free children.
  • Cooperative children classified as class 3 or 4 based on Frankel et al. classification
  • Children who had at least one active dentinal carious lesion on proximal surface of primary molars
  • Primary molars with active dentinal carious lesion on their proximal surface score 4, 5 using ICDAS.
  • Primary molars with proximal carious lesion extended to outer and middle third of dentin scored D1and D2 that will be detected by bitewing radiograph.
  • Simple or compound class II cavities be present
  • The antagonist and the adjacent tooth should be present
  • Primary molar should have at least 2/3 of the root present

You may not qualify if:

  • Refusal of the parents to sign the informed consent
  • Presence of deep bite or any pictures of malocclusion and any parafunctional habits.
  • Presence of any unprovoked pain, pulp exposure,clinical swelling, abscess or fistula.
  • Presence of any physiological or pathological mobility.
  • Very deep subgingival cavities
  • Teeth with congenitally missing successor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry ain shams university

Cairo, Egypt

RECRUITING

Study Officials

  • Sarah Emad

    faculty of dentistry ain shams university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer at the Pediatric Dentistry and Dental Public Health Department-Faculty of Dentistry

Study Record Dates

First Submitted

August 11, 2023

First Posted

August 21, 2023

Study Start

December 30, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations